NCT02234336

Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 110 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.

Detailed description

Patients receiving clinically indicated echocardiograms and cardiac magnetic resonance imaging at Mayo Clinic will be eligible.

Conditions

• Hypertrophic Cardiomyopathy

Interventions

Type	Name	Description
PROCEDURE	Noncontrast echocardiography
PROCEDURE	Contrast Echocardiography
PROCEDURE	Cardiac magnetic resonance imaging

Timeline

• Start date: 2014-10-01
• Primary completion: 2017-07-25
• Completion: 2017-07-25
• First posted: 2014-09-09
• Last updated: 2019-02-05

Locations

1 site across 1 country: United States